Adaptive Biotechnologies | 4:持股变动声明-高管 PISKEL KYLE
Adaptive Biotechnologies | SC 13G:超过5%持股股东披露文件-Rubric Capital Management LP(9.76%),David Rosen(9.76%)
Adaptive Biotechnologies | SC 13G/A:超过5%持股股东披露文件(修正)-Matrix Capital Management Company LP(0.44%),David E. Goel(0.44%)
Adaptive Biotechnologies | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G:超过5%持股股东披露文件-Nikko Asset Management Americas, Inc.(5.24%)
Adaptive Biotechnologies | 10-Q:2024财年三季报
Adaptive Biotechnologies | 8-K:自适应生物技术公布2024年第三季度财务业绩
Adaptive Biotechnologies | SC 13G:超过5%持股股东披露文件-Sumitomo Mitsui Trust Group, Inc. (“SMTG”)(5.24%),Nikko Asset Management Co., Ltd. (“NAM”)(5.24%)
Adaptive Biotechnologies | SC 13G:超过5%持股股东披露文件-The Vanguard Group(7.21%)
Adaptive Biotechnologies | SC 13G/A:超过5%持股股东披露文件(修正)-Millennium Management LLC(6.4%),Millennium Group Management LLC(6.4%)等
Adaptive Biotechnologies | 4:持股变动声明-高管 BOBULSKY SUSAN
Adaptive Biotechnologies | 4:持股变动声明-高管 Taylor Stacy L
Adaptive Biotechnologies | 144:拟议出售证券
Adaptive Biotechnologies | 10-Q:2024财年二季报
Adaptive Biotechnologies | 8-K:自适应生物技术公布2024年第二季度财务业绩
Adaptive Biotechnologies | 8-K:重大事件
Adaptive Biotechnologies | SC 13G:超过5%持股股东披露文件-Millennium Management LLC(5.3%),Millennium Group Management LLC(5.3%)等
Adaptive Biotechnologies | DEFA14A:其他
Adaptive Biotechnologies | 4:持股变动声明-高管 PISKEL KYLE
Adaptive Biotechnologies | 10-Q:2024财年一季报
暂无数据
暂无数据